Septaforce Liquid
NDC Package 43857-0620-1
Package Information
Septaforce (baptisia tinctoria, echinacea (angustifolia), arsenicum album, chininum sulphuricum, crotalus horridus, lachesis mutus, secale cornutum, tarentula cubensis, latrodectus mactans, anthracinum, loxosceles reclusa) liquids is for temporary relief of constricted feeling of the chest, palpitations with anxiety, purplish hue, burning, stinging pains, inflammation of connective tissues. This formulation utilizes a liquid delivery system. Marketed by Bioactive Nutritional, Inc., this product is identified by NDC 43857-0620.
Identification & Billing
Clinical Specifications
- ARSENIC TRIOXIDE 12 [hp_X]/mL
- BACILLUS ANTHRACIS IMMUNOSERUM RABBIT 33 [hp_X]/mL
- BAPTISIA TINCTORIA ROOT 3 [hp_X]/mL
- CITHARACANTHUS SPINICRUS 12 [hp_X]/mL
- CLAVICEPS PURPUREA SCLEROTIUM 12 [hp_X]/mL
- CROTALUS HORRIDUS HORRIDUS VENOM 12 [hp_X]/mL
- ECHINACEA ANGUSTIFOLIA WHOLE 3 [hp_X]/mL
- LACHESIS MUTA VENOM 12 [hp_X]/mL
- LATRODECTUS MACTANS 12 [hp_X]/mL
- LOXOSCELES RECLUSA 15 [hp_C]/mL
- QUININE SULFATE 12 [hp_X]/mL
Regulatory & Marketing
Hierarchy Structure
- 43857 - Bioactive Nutritional, Inc.
- 43857-0620 - Septaforce
- 43857-0620-1 - 30 mL in 1 PACKAGE
- 43857-0620 - Septaforce
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43857-0620-1 identifies a specific commercial package of 30 ml in 1 package of Septaforce, a human prescription drug labeled by Bioactive Nutritional, Inc.. This liquid is formulated for oral use and contains arsenic trioxide; bacillus anthracis immunoserum rabbit; baptisia tinctoria root; citharacanthus spinicrus; claviceps purpurea sclerotium; crotalus horridus horridus venom; echinacea angustifolia whole; lachesis muta venom; latrodectus mactans; loxosceles reclusa; quinine sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bioactive Nutritional, Inc. on November 19, 2021. The current certification is valid through December 31, 2026.
How is this Bioactive Nutritional, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43857062001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.